Lixisenatide - PDFSEARCH.IO - Document Search Engine

Lixisenatide
Results: 10

#	Item
1	Lyxumia - INN, lixisenatide Add to Reading List Source URL: www.ema.europa.eu Language: English - Date: 2013-07-21 06:40:43 Medicine Gastroenterology Diabetes Eli Lilly and Company Clinical research European Medicines Agency Anti-diabetic medication Exenatide Glucagon-like peptide-1 Anti-diabetic drugs Peptide hormones Endocrine system
2	Microsoft Word - lixisenatide-with-insulin-psddocx Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-04-22 23:39:46 Biology Eli Lilly and Company Peptide hormones Recombinant proteins Anti-diabetic drugs Insulin therapy Insulin analog Insulin glargine Insulin Medicine Endocrine system Diabetes
3	Microsoft Word - lixisenatide-dual-triple-therapy-psddocx Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-04-22 23:39:46 Medicine Peptide hormones Gastroenterology Anorectics Eli Lilly and Company Exenatide Sulfonylurea Metformin Diabetes management Anti-diabetic drugs Diabetes Endocrine system
4	5.9 LIXISENATIDE, 10 microgram/0.2 mL injection, 14 unit doses (&) 20 microgram/0.2 mL injection, 14 unit doses, Lyxumia® treatment initiation pack Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-04-22 23:39:46 Peptide hormones Eli Lilly and Company Gastroenterology Medicine Anorectics Exenatide Anti-diabetic medication Sulfonylurea Diabetes management Anti-diabetic drugs Diabetes Endocrine system
5	THE PIPELINE REPORT[removed]Latestage Standouts Spotlighting 196 agents, with profiles on 15 advances vying to be better, safer or cheaper than Add to Reading List Source URL: media.mmm-online.com Language: English - Date: 2013-05-21 21:41:53 Dipeptidyl peptidase-4 inhibitor Immunology Infliximab Rosiglitazone Diabetes mellitus type 1 Lixisenatide GlaxoSmithKline Medicine Schering-Plough Pharmacology
6	Diabetes Volume 63, February[removed]Mahesh M. Umapathysivam,1 Michael Y. Lee,1 Karen L. Jones,2 Christopher E. Annink,3 Caroline E. Cousins,3 Laurence G. Trahair,2 Chris K. Rayner,2 Marianne J. Chapman,1,3 Michael A. Add to Reading List Source URL: diabetes.diabetesjournals.org Language: English Peptide hormones Medicine Biology Eli Lilly and Company Nutrition Glucagon-like peptide-1 Exenatide Liraglutide Lixisenatide Endocrine system Anti-diabetic drugs Diabetes
7	PIPELINE 2011LAUNCH PROSPECTS MM&M’s Pipeline 2011 offers a short list of the so-called locks and long-shots to reach market over the next months and years. You’ll find details on 14 specific late-stage candidates, s Add to Reading List Source URL: media.mmm-online.com Language: English - Date: 2013-05-21 21:27:14 Vaccines Bristol-Myers Squibb Ipilimumab Cancer vaccine Gilead Sciences Influenza vaccine Lixisenatide Latrepirdine Dipeptidyl peptidase-4 inhibitor Pharmacology Pharmaceutical industry Medicine
8	Company Announcement No[removed]Zealand raises USD 50 / DKK 300 million in a royalty bond financing Unlocking part of the value of lixisenatide (Lyxumia®) to Add to Reading List Source URL: www.athyrium.com Language: English - Date: 2014-12-15 21:49:48 Sanofi Bond Lixisenatide Economics Intellectual property law Patent law Royalties
9	Microsoft Word[removed]Diabetes Forum Invite.3.doc Add to Reading List Source URL: tcoyd.org Language: English - Date: 2014-06-04 20:45:42 Diabetes Anti-diabetic drugs Eli Lilly and Company Recombinant proteins Insulin Joslin Diabetes Center Glucagon-like peptide-1 Lixisenatide Endocrine system Medicine Peptide hormones
10	PDF Document Add to Reading List Source URL: www.insightpharmareports.com Language: English - Date: 2010-09-03 10:29:03 Organic chemistry Peptide hormones Diabetes Dipeptidyl peptidase-4 inhibitors Eli Lilly and Company Anti-diabetic medication Exenatide Lixisenatide Sitagliptin Anti-diabetic drugs Chemistry Endocrine system

UPDATE